Class / Patent application number | Description | Number of patent applications / Date published |
514186000 | Bicyclo ring system | 69 |
20080227766 | Synergistic, Silver-Containing Biocide Composition - A biocidal composition comprising a combination of at least two biocidal components, in which 1,2-benzisothiazolin-3-one and/or N-methyl-1,2-benzisothiazolin-3-one and/or N-methyl-1,2-benzisothiazolin-3-one are used as one component and silver in the form of, for example, organic or inorganic silver salts, colloidal or nanoparticulate silver or silver oxide is used as the other component, has a broad spectrum of activity against diverse bacteria and fingi. | 09-18-2008 |
20080242652 | Indole derivatives and their metal conjugates and uses thereof - Provided are compounds which are indole derivatives, as well as pharmaceutical compositions containing the compounds. Also provided are methods of using the indole compounds for preventing or treating a disease, or a condition that predisposes to a disease, wherein the disease or condition is associated with activation of the serine/threonine kinase B (Akt) in an animal. The method comprises administering to the animal a preventive or treatment effective amount of the indole compound. Further provided is a method for increasing apoptosis of an animal cell comprising contacting the cell with the indole compound. | 10-02-2008 |
20080280866 | Method of Treating or Sepsis - Provided is a method of treating trauma or sepsis comprising: administering an effective amount of one or both of a SOC channel-selective inhibitor or a SphK inhibitor to an animal at risk of inflammation-mediated organ damage from trauma or sepsis. | 11-13-2008 |
20090018110 | Haptoglobin genotyping for prognosis and treatment of chronic vasospasm following subarachnoid hemorrhage (SAH) - This invention relates to methods and systems for providing a prognosis to a subject on developing vasospasm as a results of hemorrhagic event, and compounds and compositions for treatment thereof. Specifically, the invention relates to the use of haptoglobin genotyping in the prognosis of the development of vasospasm following SAH, and antioxidants such as glutathione peroxidase mimetics for treatment. | 01-15-2009 |
20090318402 | RUTHENIUM (II) COMPOUNDS - A ruthenium (II) compound of formula (I) wherein X is halo or a neutral or negatively charged O, N- or S-donor ligand; Y is a counterion; m is 0 or 1; q is 1, 2 or 3; A is either: (i) ( | 12-24-2009 |
20100075939 | Immobilized 1,2-benzisothiazolin-3-one - The present invention provides novel antimicrobial immobilized 1,2-benzisothiazolin-3-one/zinc oxide (BIT/ZnO) complexes useful as antimicrobial agents because of their resistance to being leached from the substrate to which they are attached. The present invention is also directed to methods for preparing the BIT/ZnO complexes, to BIT/ZnO complexes prepared by the novel methods, to methods for using the BIT/ZnO complexes to inhibit microbial growth or reduce the level of bacteria on the surface of a substrate, and to substrates protected from microbial attack by being treated with the BIT/ZnO complexes. The present invention is further directed to compositions comprising 1,2-benzisothiazolin-3-one which has been immobilized with zinc oxide. | 03-25-2010 |
20100075940 | DENDRITIC POLYAMIDOAMINE PHTHALOCYANINE DERIVATIVE - The present invention is directed to a dendritic polyamidoamine phthalocyanine derivative which is useful as, for example, a fluorescent material or a photodynamic therapeutic drug for cancer. The derivative is represented by the following formula (1): | 03-25-2010 |
20100137272 | Zinc Salt Of Isothiazolone Compound, Method For Reducing Irritation Caused By Isothiazolone Compound, Antibacterial and Antifungal Method Using Zinc Salt of Isothiazolone Compound, and Antibacterial and Antifungal Composition - There are provided, according to the present invention, a zinc salt of an isothiazolone compound represented by the following formula (1); a method for reducing the extent of irritation by converting the isothiazolone compound represented by the formula (1) into a zinc salt; an antibacterial and antifungal method using the zinc salt; and an antibacterial and antifungal composition including at least one kind of the zinc salt, | 06-03-2010 |
20100144693 | METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) - The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions. | 06-10-2010 |
20100210616 | METAL COMPLEXES INCORPORATED WITHIN BIODEGRADABLE NANOPARTICLES AND THEIR USE - Compounds for antimicrobial applications, and for treating bacterial and fungal infection are set forth. The compounds may include a metal complex incorporated into a biodegradable polymeric nanoparticle. Also, a method of treating bacterial and fungal infections in a mammal includes the steps of administering an effective amount of a silver(I) metal salt incorporated into a biodegradable polymeric nanoparticle. | 08-19-2010 |
20100273763 | ORGANOMETALLIC COMPLEXES AS THERAPEUTIC AGENTS - This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use. These analogues have therapeutic activity including anticancer activity. | 10-28-2010 |
20100292202 | FUNGICIDAL COMPOSITIONS FOR TURF TREATMENT AND IMPROVEMENT - The present invention relates to novel compositions comprising a fungicide that inhibits mitochondrial respiration at the QoI site, (QoI inhibitor), a contact fungicide, a demethylation inhibitor and pigments, which are highly suitable for controlling unwanted phytopathogenic fungi. Moreover, the fungicidal compositions are able to control mold and fungus infection in grasses, in particular turf grasses. | 11-18-2010 |
20100305084 | BICYCLIC INDOLE-PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE - Formula I (Ia and Ib) compounds wherein (i) X | 12-02-2010 |
20110009376 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR EYE DISEASE ACCOMPANIED BY OPTIC NERVE DISORDER - The present invention provides a novel pharmaceutical use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof. 2-Phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof exhibits an excellent suppressive effect on retinal ganglion cell death in a pharmacological test using rats, and is therefore useful as a prophylactic or therapeutic agent for an eye disease accompanied by optic nerve disorder. | 01-13-2011 |
20110021485 | INDOLE DERIVATIVES AND THEIR METAL CONJUGATES AND USES THEREOF - Provided are compounds which are indole derivatives, as well as pharmaceutical compositions containing the compounds. Also provided are methods of using the indole compounds for preventing or treating a disease, or a condition that predisposes to a disease, wherein the disease or condition is associated with activation of the serine/threonine kinase B (Akt) in an animal. The method comprises administering to the animal a preventive or treatment effective amount of the indole compound. Further provided is a method for increasing apoptosis of an animal cell comprising contacting the cell with the indole compound. | 01-27-2011 |
20110086830 | METAL COMPLEXES OF N-HETEROCYCLIC CARBENES - The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H | 04-14-2011 |
20110172199 | PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The invention relates to the platinum N-heterocycle derivatives of general formula (I) | 07-14-2011 |
20110230456 | Nitridoosmium(VI) Complexes for Treatment of Cancer - The invention relates to nitridoosmium complexes and methods of using these compounds as treatments for cancer. | 09-22-2011 |
20110306585 | Metal Complexes of N-Heterocyclic Carbenes - The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H | 12-15-2011 |
20120071456 | COMPOSITION - Hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer. | 03-22-2012 |
20120115833 | METHOD OF TREATING HEPATOCELLULAR CARCINOMA - A therapeutic method for treating hepatocellular carcinoma is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 05-10-2012 |
20120178730 | SOD-IMITATING METAL COMPLEXES - The present invention comprises a process to synthesise metal complexes from macrocyclic polyazapyridinophane compounds characterised as superoxide dismutase enzyme (SOD) mimetics. Furthermore, the present invention relates to the macrocyclic polyazapyridinophane compounds themselves, the metal complexes formed from these and to their use in the treatment of diseases the aetiology of which is based on disturbances in the activity of, or a deficiency in endogenous SOD, mainly as anti-inflammatories, analgesics and antioxidant compounds providing protection against cellular oxidative stress. | 07-12-2012 |
20120302538 | SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS - The present disclosure provides substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes, of Formula I | 11-29-2012 |
20130018028 | Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate)AANM Farag; Christine MaherAACI LakelandAAST FLAACO USAAGP Farag; Christine Maher Lakeland FL US - Bi-(indole-2-aceto)-iron II, also named ferrous bis(indole acetate), or a pharmaceutically acceptable salt thereof, wherein: —Fe (Iron) is substituted by another transition metal capable of bonding to two molecules of indole acetate is synthesized for medicinal purposes including treatment of solid tumor cancers and other vascular proliferative disorders. This invention also extends to the substitution of the ligands by one or more of the structural analogues of indole acetetate disclosed in this application. In certain aspects, the compositions of the invention are capable of generating both a vascular targeting effect and tumor cell cytotoxicity (e.g. by oxidative stress) in order to achieve an enhanced anti-tumor response. | 01-17-2013 |
20130023511 | ORGANOMETALLIC COMPLEXES AS THERAPEUTIC AGENTS - This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use. These analogues have therapeutic activity including anticancer activity. | 01-24-2013 |
20130090320 | METHOD OF TREATING PROSTATE CANCER - A therapeutic method for treating prostate cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 04-11-2013 |
20130096098 | Light Insensitive Silver(i) Cyanoximates As Antimicrobial Agents For Indwelling Medical Devices - Silver(I) cyanoximates of AgL composition (L=NC—C(NO)—R, where R is electron withdrawing groups: —CN, —C(O)NR | 04-18-2013 |
20130096099 | METHOD OF TREATING BRAIN CANCER - A therapeutic method for treating brain cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 04-18-2013 |
20130109662 | Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias | 05-02-2013 |
20130131031 | METHOD OF TREATING REFRACTORY CANCER - Therapeutic methods for treating refractory cancers are disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 05-23-2013 |
20130190285 | METHOD OF TREATING PANCREATIC CANCER - A therapeutic method for treating pancreatic cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 07-25-2013 |
20130296287 | FOCAL PHOTODYNAMIC THERAPY METHODS - Improved methods of treating prostate cancer by vascular-targeted photodynamic therapy, and improved methods of planning treatment, are presented using a light density index to plan and guide effective treatment. | 11-07-2013 |
20130296288 | ORGANIC ELECTROLUMINESCENT DEVICE - The present invention relates to a salt in which at least one cation and at least one anion is in each case an emitter compound or a dye compound, characterised in that at least one of the emitter compounds is a fluorescent emitter compound. In addition, the present invention also relates to a process for the preparation of the salt according to the invention, to the use of the salt in an electronic device, and to a formulation and an electronic device which comprises the salt. | 11-07-2013 |
20130324512 | SUPER-OXIDE DISMUTASE MIMETICS - The present invention relates to compounds which are effective as catalysts for dismutating superoxide and, more particularly, the manganese or iron complexes of substituted, unsaturated heterocyclic 16-membered macrocyclic complexes that catalytically dismutate superoxide. It also relates to methods of using these complexes to reduce the concentration or the effects of superoxide, pharmaceutical compositions comprising these compounds or their metal complexes, and methods of treating conditions associated with excessive superoxide activity. | 12-05-2013 |
20130331368 | METHOD OF TREATING HEPATOCELLULAR CARCINOMA - A therapeutic method for treating hepatocellular carcinoma is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 12-12-2013 |
20130338128 | PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The invention relates to the platinum N-heterocycle derivatives of general formula (I) | 12-19-2013 |
20130338129 | METHOD OF TREATING REFRACTORY CANCER - Therapeutic methods for treating refractory cancers are disclosed comprising administering to a patient in need of treatment a ruthenium complex salt. | 12-19-2013 |
20140162994 | FE(III) COMPLEX COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANEMIAS - The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anemias. | 06-12-2014 |
20140274988 | DUAL TARGETING ANTICANCER AGENTS - Methods, compounds, and compositions for treating a proliferative disorder or other physiological conditions via a dual targeting anticancer therapy are provided. In some embodiments, a dual targeting anticancer therapy may utilize a composition comprising a platinum agent. The platinum agent may comprise a precursor to a therapeutically active platinum compound and at least one precursor to a vitamin E agent. The vitamin E agent may target cancer cells via a different mechanism of action than the therapeutically active platinum compound resulting in a dual targeting anticancer agent. The method of treatment may involve administering to a patient the dual targeting anticancer agent. Following administration, a therapeutically active platinum compound and a vitamin E agent may form at the physiologically relevant site. In some embodiments, administering a platinum agent comprising precursors of therapeutically active agents may be more effective than individually or simultaneously administering separate molecules of those therapeutically active agents. | 09-18-2014 |
20140323458 | SUBSTITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS - The present disclosure provides substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes, of Formula I | 10-30-2014 |
20140371193 | ORGANOMETALLIC COMPLEXES AS THERAPEUTIC AGENTS - This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use. These analogues have therapeutic activity including anticancer activity. | 12-18-2014 |
20150065475 | Turfgrass Fungicide Formulation with Pigment - Oil-in-water fungicidal formulations are prepared having pigment dispersed therein, the pigment being stable within the oil-in-water emulsion as a result of the addition of suitable silicone surfactants and suitable emulsifiers. The formulations can be prepared either as a 2-pack formulation or as a single formulation. In the case of the single formulation polyethylene glycol is also added. In either case, the formulations show a synergistic effect through the addition of the pigment, the resulting formulations having an increased efficacy. Further, the formulations show a synergistic effect when mixed with conventional chemical fungicides, both being added in reduced amounts compared to recommended rates. | 03-05-2015 |
20150119374 | FE(III)-PYRAZINE COMPLEX COMPOUNDS FOR TREATMENT AND PROPHYLAXIS OF IRON-DEFICIENCY PHENOMENA AND IRON-DEFICIENCY ANAEMIA - The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anemias. | 04-30-2015 |
20150368281 | Platinum Compounds Of Malonic Acid Derivative Having Leaving Group Containing Amino Or Alkylamino - Disclosed are a class of platinum compounds of malonic acid derivatives having a leaving group containing an amino or alkylamino, and pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition containing the compounds. Also disclosed are uses of the compounds for treating cell proliferative diseases especially cancers. The platinum compounds of the present invention have high solubility in water, low toxicity and strong anti-tumor effect. | 12-24-2015 |
514187000 | Quinolines or isoquinolines (including hydrogenated) | 25 |
20110144079 | ANTIMICROBIAL SYSTEM - The present invention relates to the use of ionic liquids as antimicrobial agents, and to the use of antimicrobial compositions comprising an ionic liquid, a film-enhancing composition and a viscosity controlling agent. The invention further relates to methods of disinfecting substrate surfaces, to substrates produced by such methods, and to novel ionic liquid compositions. | 06-16-2011 |
20110257146 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds - The instant invention describes methods of treating KCNQ related diseases and disorders using organozinc compounds. In certain embodiments, pain is treated using Zinc Pyrithione. | 10-20-2011 |
20120022036 | Method of treating osteoporosis - A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof. | 01-26-2012 |
20120135973 | METHOD FOR TREATING CHRONIC PAIN - The present invention provides analgesic compounds comprising at least one modified metalloporphyrin compound. Also provided are methods of treating pain by orally administering an analgesic compounds comprising at least one modified metalloporphyrin compound. | 05-31-2012 |
20120258945 | Association Between Ferroquine and an Artemisinine Derivative for Treating Malaria - This invention is directed to methods for the treatment and prevention of malaria comprising administering a combination of ferroquine, or a pharmaceutically acceptable salt, hydrate or solvate thereof, and an artemisinin derivative, and to pharmaceutical compositions comprising such combination. | 10-11-2012 |
20120270851 | USE OF FERROQUINE IN THE TREATMENT OR PREVENTION OF MALARIA - The present invention relates to the use of ferroquine or its N-demethylated metabolite or any of the pharmaceutically acceptable salts thereof for treating and/or preventing infections caused by the parasite | 10-25-2012 |
20130065873 | METAL COMPLEXES - The present invention relates, inter alia, to metal complexes having improved solubility, process for the preparation of the metal complexes, devices comprising these metal complexes, and the use of the metal complexes. | 03-14-2013 |
20130090321 | METHOD FOR TREATING BRAIN CANCER - Methods and compositions for treating brain cancer are disclose including refractory brain cancer. | 04-11-2013 |
20130090322 | METHOD OF TREATING PANCREATIC CANCER - A therapeutic method for treating pancreatic cancer is disclosed comprising administering to a patient in need of treatment a gallium complex according to Formula (I) provided herein. | 04-11-2013 |
20130109663 | N6-(FERROCENMETHYL)QUINAZOLIN-2,4,6-TRIAMINA (H2) AND THE DERIVATIVES AND PRODRUGS THEREOF AS ANTILEISHMANIAL, ANTIPROTOZOAL, ANTIPARASITIC AND ANTIMICROBIAL AGENTS | 05-02-2013 |
20130116225 | METHOD FOR TREATING HEMATOLOGICAL CANCERS - Methods and compositions for treating hematological cancer are disclosed, including refractory or resistant hematological cancer. | 05-09-2013 |
20130116226 | METHOD FOR TREATING ESOPHAGEAL CANCER - Methods and compositions for treating gastric and esophageal cancers are disclosed. | 05-09-2013 |
20130237511 | Copper Ion Delivery Platform for Pharmaceutical Agents - Methods for utilizing copper ions to bind to and help transport medicinal agents that contain a nitrogen atom or atoms are disclosed. The copper ion or ions serve as a delivery platform for a known pharmaceutical agent. The copper ions may be used to impact the polarity of the medicinal agents so they perform more efficiently in a physiological environment. The copper ions may also improve the efficacy of the drug by impacting their stability. | 09-12-2013 |
20130310356 | METHOD FOR TREATING BRAIN CANCER - Methods and compositions for treating brain cancer are disclosed, including refractory brain cancer. | 11-21-2013 |
20130316998 | METHOD FOR TREATING PANCREATIC CANCER - A therapeutic method for treating pancreatic cancer is disclosed comprising administering to a patient in need of treatment a gallium complex according to Formula (I) provided herein. | 11-28-2013 |
20130324513 | METHOD FOR TREATING ESOPHAGEAL CANCER - Methods and compositions for treating gastric and esophageal cancers are disclosed. | 12-05-2013 |
20140005159 | METHOD OF TREATING OSTEOPOROSIS | 01-02-2014 |
20140005160 | Method for Treating Refractory Cancer | 01-02-2014 |
20140088066 | PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER - The present disclosure relates to novel pharmaceutical compositions comprising a nanoparticle associated with, tether to, or encapsulating a platinum-based active pharmaceutical agent. The platinum-based drug is released from the nanoparticles in a controlled fashion. Also contemplated are methods of making the nanoparticles, as well as methods for using them in the treatment or prevention of diseases or conditions. One embodiment relates to phenanthriplatin nanoparticles and methods of using and making the same. | 03-27-2014 |
20140155367 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES - The present invention provides compounds of formula I: | 06-05-2014 |
20150011522 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES - The present invention provides compounds of formula I: | 01-08-2015 |
20160039854 | METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND THEIR USE - Compositions of the invention include metal-based coordination complexes, which are preferably tunable photodynamic compounds. The compositions and complexes are useful as therapeutic agents and as in vivo diagnostic agents for treating or preventing diseases including those that involve hyperproliferating cells in their etiology, such as cancer. Compositions and complexes of the invention are further capable of destroying microbial cells, such as bacteria, fungi, and protozoa, and destroying viruses. The compositions and complexes are also capable of modulating cell function in other ways. | 02-11-2016 |
20160095865 | APPLICATION OF ENROFLOXACIN SALT IN PREPARATION OF ORAL PREPARATION FOR PIGS - The invention discloses application of an enrofloxacin salt in preparation of an oral preparation for pigs. The enrofloxacin salt is at least one of salts formed by enrofloxacin and metal ions, and the metal ions are zinc, copper, calcium, magnesium, iron, cobalt, manganese, chromium, silver or nickel. The enrofloxacin salt formed by the enrofloxacin and the metal ions can significantly improve the palatability of the enrofloxacin to pigs; furthermore pharmacokinetics and artificial infection prove that the enrofloxacin salt formed by the enrofloxacin and the metal ions does not affect bioavailability, so enrofloxacin salt can be developed into the oral preparation administrated via the digestive tract, for pig-raising without affecting normal feed intake of the pigs. | 04-07-2016 |
20160152646 | PLATINUM COMPOUNDS HAVING A HETEROCYCLE LIGAND, NANOPARTICLES, AND USES THEREOF | 06-02-2016 |
20180022771 | CYMANQUINE COMPOUNDS AND DERIVATIVES THEREOF AND USES THEREOF | 01-25-2018 |